Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aevi Genomic Medicine, Llc, A Cerecor Company

Clinical trials sponsored by Aevi Genomic Medicine, Llc, A Cerecor Company, explained in plain language.

Now part of Avalo Therapeutics, Inc. AVTX NASDAQ

A subsidiary of Cerecor, focused on genomic medicine for rare diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Personalized ADHD drug shows promise in early trial for teens

Disease control Completed

This early-stage study tested a drug called NFC-1 in 30 adolescents aged 12-17 with ADHD who also have specific genetic changes affecting brain receptors. The goal was to check the drug's safety and how the body processes it, while also looking for signs it might reduce ADHD symp…

Phase: PHASE1 • Sponsor: Aevi Genomic Medicine, LLC, a Cerecor company • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC